TY  - JOUR
AU  - Shumilov, Evgenii
AU  - Scholz, Julia Katharina
AU  - Seib, Maximilian
AU  - Mazzeo, Paolo
AU  - Wurm-Kuczera, Rebecca
AU  - Vucinic, Vladan
AU  - Holtick, Udo
AU  - Boyadzhiev, Hristo
AU  - Melchardt, Thomas
AU  - Hölscher, Alexander
AU  - Schultze-Florey, Christian
AU  - Abdelhafez, Atef
AU  - Velazquez, Giuliano Filippini
AU  - Ossami Saidy, Anna
AU  - Lesan, Vadim
AU  - Schnetzke, Ulf
AU  - Kerkhoff, Andrea
AU  - Bacher, Ulrike
AU  - Ghandili, Susanne
AU  - Aydilek, Enver
AU  - Gebauer, Niklas
AU  - Weber, Thomas
AU  - Wulf, Gerald
AU  - Glass, Bertram
AU  - Thurner, Lorenz
AU  - Heidel, Florian H
AU  - Schmid, Christoph
AU  - Viardot, Andreas
AU  - Hänel, Mathias
AU  - Dietrich, Sascha
AU  - Pabst, Thomas
AU  - Ayuk, Francis
AU  - von Tresckow, Bastian
AU  - Chapuy, Björn
AU  - Pott, Christiane
AU  - Müller, Fabian
AU  - Lenz, Georg
TI  - Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma.
JO  - Blood advances
VL  - 9
IS  - 15
SN  - 2473-9529
CY  - Washington, DC
PB  - American Society of Hematology
M1  - DKFZ-2025-01604
SP  - 3955 - 3966
PY  - 2025
AB  - Patients with large B-cell lymphoma (LBCL) who experience relapsed disease after CD19-directed chimeric antigen receptor (CAR) T-cell (CAR-T) therapy have a poor prognosis. Bispecific antibodies (BsAbs) induce complete remissions in ∼35
KW  - Humans
KW  - Antibodies, Bispecific: therapeutic use
KW  - Male
KW  - Female
KW  - Middle Aged
KW  - Immunotherapy, Adoptive: methods
KW  - Immunotherapy, Adoptive: adverse effects
KW  - Aged
KW  - Lymphoma, Large B-Cell, Diffuse: therapy
KW  - Lymphoma, Large B-Cell, Diffuse: mortality
KW  - Lymphoma, Large B-Cell, Diffuse: drug therapy
KW  - Lymphoma, Large B-Cell, Diffuse: pathology
KW  - Adult
KW  - Recurrence
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Receptors, Chimeric Antigen
KW  - Aged, 80 and over
KW  - Antibodies, Bispecific (NLM Chemicals)
KW  - Receptors, Chimeric Antigen (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:40238938
DO  - DOI:10.1182/bloodadvances.2024015719
UR  - https://inrepo02.dkfz.de/record/303259
ER  -